Sid Labed
Chief Executive Officer (CEO)
About us
Who We Are!
EvoDenovo is a next-generation biopharmaceutical company dedicated to advancing treatments for mental health disorders. Our multidisciplinary team combines state-of-the-art scientific research with clinical expertise to develop fast-acting, non-addictive therapies for depression and substance use disorders. We are committed to addressing critical unmet medical needs through rigorous research and translational science, transforming innovative discoveries into effective patient care.
Our Mission Statement
At EvoDenovo, our mission is to redefine mental health care by leveraging cutting-edge research to develop safe, effective, and sustainable therapeutic solutions. We are committed to the highest standards of scientific excellence and regulatory rigor, focusing on both the symptomatic relief and the underlying biological mechanisms of depression and addiction. By integrating advanced technologies with strategic collaborations, we strive to accelerate the development of novel treatments that offer rapid, lasting benefits. Our goal is to empower healthcare professionals and patients alike, setting new benchmarks in mental health care and contributing to a healthier, more resilient future.
DEPRESSION PROBLEM
Depression
Risk of Suicide:
Depression is a leading cause of Suicide
7% Adults
Over 17 million people in US had sever depression episode.
Economic Consequences
economic burden of depression in the US was estimated to be over $210 billion in 2019
DEPRESSION SOLUTION
Revolutionizing Depression Treatment with Biologics
EvoDenovo is advancing the future of depression treatment with cutting-edge biologic therapeutics. Our proprietary nanobody technology is designed to overcome the limitations of traditional antidepressants, delivering rapid, targeted, and long-lasting relief. By addressing the urgent need for innovative, non-addictive solutions, we are pioneering a new era in mental health care.
ADDICTION PROBLEM
Opioid Use Disorder
Overdose
120K died yearly overdosing on opioids
Epidemiology
Over 16 million people worldwide
Opioid side-effects
Including euphoria, dependence and tolerance
ADDICTION SOLUTION
The Anti-Opioid System
The anti-opioid systems counteract opioid signaling by directly interacting with the mu-opioid receptor, dampening the receptor-mediated intracellular signaling, or acting at the system's level. Block the anti-opioid system will augment opioid analgesia and reduce side effects.
AntiOpioids
ANTIDEPRESSANTS
Contact us
For more information about EvoDenovo please contact us today using the form below:
Collaborators
